Dr. Keshav Deo is a distinguished pharmaceutical leader with extensive experience spanning research, process development, and manufacturing. Beginning his career at Lupin, he has held senior positions at leading organizations including Sun Pharma, Dai-Ichi Laboratories, Ranbaxy, Alembic, and Wockhardt.
A prolific innovator, Dr. Deo has over 450 global patent applications to his credit and serves on the boards of several Indian pharma companies. He is also a Scientific Advisor to Cempra Pharmaceutical Inc. and PDLH (USA) and an esteemed Ph.D. supervisor at multiple Indian universities.
In 2019, he founded Lifeactivus Private Limited to advance sustainable innovations in dietary supplements, complex generics, and industry-academia collaborations. Under his leadership, the company has filed 15 patents, registered 10 trademarks, and secured its first US patent. Notable breakthroughs include Lifevirotreat, an aerosol-based COVID-19 treatment, anti-aging solutions, and the development of Prussian Blue, a critical API for radio injury treatment and also serves as Executive Director at Almelo Private Limited
Dr. Deo holds a Ph.D. from the Central Drug Research Institute, Lucknow, under Dr. D.S. Bhakuni, and a master’s degree from Agra University. His research expertise spans chemo- and regioselective reductions, asymmetric catalysis, biocatalysis, and API process development-driving Lifeactivus’s vision for sustainable innovation in life sciences.



